You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
20 December 2021
GlaxoSmithKline (GSK) has named the chair and management team for its Consumer Healthcare business following the planned separation in 2022.
11 November 2021
GlaxoSmithKline (GSK) Consumer Healthcare has increased product prices in China, Europe and the US in recent months, according to Brian McNamara, chief executive officer of the business.
13 October 2021
GlaxoSmithKline (GSK) has named the location of new global headquarters for its Consumer Healthcare business following the planned separation in 2022. The news came as media reports suggested several private-equity firms were interested in acquiring the business.
9 September 2021
Karo Pharma has hired GlaxoSmithKline (GSK) Consumer Healthcare’s Anna Hale as chief marketing officer.
2 August 2021
E-commerce accounts for around 7% of GlaxoSmithKline (GSK) Consumer Healthcare’s total sales, according to chief executive officer Brian McNamara, but the business is “underdeveloped” compared to its industry peers in the vitamins, minerals and supplements (VMS) category.
2 August 2021
Six of GlaxoSmithKline (GSK) Consumer Healthcare’s nine powerbrands recorded double-digit sales growth in the second quarter of 2021, according to chief executive officer Brian McNamara.
23 July 2021
GlaxoSmithKline (GSK) has announced that Brian McNamara will remain chief executive officer of its Consumer Healthcare business following the planned separation in 2022.
5 July 2021
GlaxoSmithKline (GSK ) will “evaluate any alternative options for Consumer Healthcare that may arise”, according to the company’s board, which says it is close to appointing a chief executive officer designate for the business ahead of the proposed separation.
2 July 2021
Activist investor Elliott Investment Management is urging GlaxoSmithKline (GSK) to consider selling its Consumer Healthcare business rather than going ahead with the proposed separation.
24 June 2021
GlaxoSmithKline (GSK) has confirmed plans to demerge its Consumer Healthcare business in mid 2022. The company says New Consumer Healthcare will have 20 brands each with sales in excess of GBP100 million (USD140 million).